Pharmacoepidemiology in Clinical Research
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 13372
Special Issue Editors
2. Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain
Interests: adverse drug reactions; drug safety; pharmacoepidemiology; effectiveness; pharmacovigilance; patient safety
2. Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain
Interests: pharmacoepidemiology; pharmacovigilance; drug utilization
Special Issue Information
Dear Colleagues,
Pharmacoepidemiology refers to the study under real conditions and in large populations of the use, efficacy, and risks of drugs. With the constant approval of new drugs, there is a need to know their beneficial effects and the magnitude of risks in routine clinical practice. First, we must confirm and explore how efficacy demonstrated in clinical trials translates to the real world. Second, pharmacovigilance actions need safety studies when drugs are used in a larger number of patients, and in patients who have multiple comorbidities and are polymedicated. With the aim of improving therapeutic decision making and patient health outcomes, the use of real-world data is increasing, as is the use of electronic health databases at the primary care and hospital level. As a consequence, new pharmacoepidemiological and statistical methods are being developed and should be disseminated to the scientific community.
With this Special Issue, the Journal of Clinical Medicine offers researchers the opportunity to showcase the scope of pharmacoepidemiology to a wide audience and the relevance of this discipline in usual clinical practice. We invite researchers to submit both original research and review articles that explore all of these aspects. We are especially looking for manuscripts dealing with real-world data studies from electronic health databases, patient registries, pharmacy registries, etc. with a relevant impact on patient health.
Dr. Eva Montané
Dr. Mònica Sabaté
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adverse drug reactions
- drug safety
- pharmacoepidemiology
- effectiveness
- pharmacovigilance
- drug utilization
- real-world evidence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.